Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Kamal Hamed > Profile

Kamal Hamed

Affiliations

Chief Medical Officer at Spero Therapeutics Inc. (SPRO), 2024-02-06

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
SPRO	$1.37	28,075	$38,462.75	788,117	2024-02-02	Filing
SPRO	$1.27	39,496	$50,159.92	576,461	2023-09-13	Filing